Real-World Data of Sex Differences in Atrial Fibrillation Catheter Ablation: Insights from a Prospective Multicenter Registry
<h2>Abstract</h2><h3>Background</h3> Sex differences in atrial fibrillation (AF) ablation strategies and outcomes remain insufficiently characterized. <h3>Objective</h3> To evaluate the impact of sex on ablation strategies and clinical outcomes in patients with paroxysmal (PAF) and persistent AF (PsAF) in real-world settings. <h3>Methods</h3> Data from the REAL-AF Registry were analyzed (January 2018-May 2023). Demographics, intraoperative parameters, and outcomes were compared by sex, stratified by AF type. <h3>Results</h3> A total of 4,202 patients (41.1% women) were included. Women were older (69.02 ± 9.18 vs. 65.32 ± 10.49 years), had higher CHA2DS2-VASc scores (3.36±1.43 vs. 2.33±1.45), and were more frequently diagnosed with PAF (72.8% vs. 61.3%) (p<.001 for all). Across both AF types, women underwent more complex ablation procedures, including additional substrate modification (SM) (pulmonary vein isolation [PVI] + cavotricuspid isthmus [CTI] + SM: 25.8% vs. 22.7%, p=0.020), particularly posterior wall isolation (53.9% vs. 45.7% in PsAF; 18.2% vs. 12.3% in PAF). Generalized linear mixed models revealed similar acute success (first-pass PVI) between sexes; however, women required more repeat ablations after the blanking period (7.2% vs. 5.5%, p=0.022). Multivariable COX analysis showed women had a significantly higher long-term recurrence risk (adjusted HR 1.24, 95% CI: 1.06–1.45, p=0.009). Subgroup analysis identified female sex as an independent predictor of recurrence in ablation strategies incorporating SM, while PVI-only and PVI+CTI approaches yielded comparable outcomes. Complication rates were comparable, but women with PsAF had a higher incidence of vascular access complications (1.3% vs. 0.1%, p=0.010). <h3>Conclusions</h3> Women face higher long-term arrhythmia recurrence risks, especially in ablation strategies involving SM, despite comparable acute and short-term outcomes.
Authors
- Daniela Hincapie (ORCID: https://orcid.org/0000-0002-0370-5618)
- Allyson L. Varley (ORCID: https://orcid.org/0000-0002-1851-6502)
- Zhuxin Zhang (ORCID: https://orcid.org/0000-0001-6048-6610)
- Julia McHugh (ORCID: https://orcid.org/0000-0002-6894-4003)
- Anil Rajendra (ORCID: https://orcid.org/0000-0001-7607-1479)
- Paul C. Zei (ORCID: https://orcid.org/0000-0002-3681-2321)
- Linda Justice
- Matthew Sackett
- Christopher Thorne
- Imdad Ahmed
- Alexandru Costea
- Anthony Moretta
- Sandeep Goyal
- William H. Sauer
- Subha Varahan
- Yan Yao
- Joshua Silverstein
- Jose Osorio
- Benjamin D’Souza
- Yaariv Khaykin
- Ann Lowery Black
- Mouhannad Sadek
- Gustavo Morales
- Mohammad Ali Jazayeri
Institutions
- Brigham and Women's Hospital (US)
- Trinity Health (US)
- Allegheny Health Network (US)
- Mercy Health System (US)
- Chinese Academy of Medical Sciences & Peking Union Medical College (CN)
- Fudan University (CN)
- Piedmont Atlanta Hospital (US)
- Southlake Regional Health Center (CA)
- Health Net (US)
- Clinical Research Solutions (US)
- Oklahoma Heart Hospital (US)
- Sarasota Memorial Hospital (US)
- The Arrhythmia Institute (US)
- Zhongshan Hospital (CN)
- Christ Hospital (US)
- Centra Health (US)
- University of Pennsylvania (US)
Publication Details
- Journal
- Heart Rhythm O2
- Published
- 2026-04-01
- DOI
- https://doi.org/10.1016/j.hroo.2026.04.005
- Primary Topic
- Atrial Fibrillation Management and Outcomes
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Johnson and Johnson